Note: study does not discuss Lynch Syndrome
Ovarian cancer
"...These findings rationalize genetic testing for all women with ovarian
cancer, which is currently not the standard of care. We need to inform
women of the benefits of this option." "
Research partners
The study "A
targeted analysis identifies a high frequency of BRCA1 and BRCA2
mutation carriers in women with ovarian cancer from a founder
population" was co-authored by Moria H. Belanger and Lena Dolman of
McGill University; Suzanna L. Arcand of the RI-MUHC; Zhen Shen and
George Chong of the Jewish General Hospital; Anne-Marie Mes-Masson and
Diane Provencher of Centre de recherche du Centre Hospitalier de
l'Université de Montréal and Institut du cancer de Montréal; and
Patricia N Tonin of the RI-MUHC and McGill University.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.